Table_1_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

“…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”

Table 1_The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.xlsx by Rida Rehman (11120838)

“…</p>Methods<p>A closed, blunt, weight-drop mild TBI protocol was employed. …”

Image_1_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

“…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”

Image_2_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

“…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”

Table_1_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

“…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”

Table 2_The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.docx by Rida Rehman (11120838)

“…</p>Methods<p>A closed, blunt, weight-drop mild TBI protocol was employed. …”

Image 1_The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.tif by Rida Rehman (11120838)

“…</p>Methods<p>A closed, blunt, weight-drop mild TBI protocol was employed. …”

Image_4_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

“…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”

Image_2_Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microsco... by Paula Dlugosz (6400175)

“…Details of this pathway are still not fully understood since the participating components are highly variable and create a complex mixture of interacting molecules. Reelin is proteolytically processed resulting in five different fragments some of which carrying the binding site for two different but highly homologous receptors, apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR). …”

Control experiment for non-specific adsorption of glucocorticoids to incubation vials by Anagnostis Valotis (78692)

PFC and CD68⁺-macrophage accumulation during early infection time course (<b>0–8 dpi</b>). by Stephanie Weibel (127241)

“…<p>(<b>A</b>) timeline - 1936-MEL melanoma-bearing athymic nude mice were i.v. injected with emulsified PFC in each case 4 days before tumors were harvested. 1×10⁷ pfu of GLV-1h68 was i.v. administered at day 0 and tumors were harvested for <i>ex vivo </i>¹⁹F MRI at 0, 2, 4, 6 and 8 dpi (2 tumors/time point). …”

Effect of co-treatment with EGCG and PEF on the protein levels of Bcl-2 and Bax. by Chih-Hsiung Hsieh (4631161)

“…The cells co-treated with 20 μM EGCG and 60 V/cm PEF showed significant decrease of Bcl-2 and increase of Bax. …”

DataSheet1_Canadian aging and inactivity study: Spaceflight-inspired exercises during head-down tilt bedrest blunted reductions in muscle-pump but not cardiac baroreflex in older p... by Farshid Sadeghian (13835530)

“…Twenty healthy men and women aged 55 to 65, randomly divided into control and exercise groups (male control (MC, n = 5), male exercise (ME, n = 5), female control (FC, n = 6), female exercise (FE, n = 4)) (age: 58.7 ± 0.5 years, height: 1.67 ± 0.02 m, body mass: 70.2 ± 3.2 kg; mean ± SEM), completed the study. …”

Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor by Chih-Sheng Chu (395925)

“…Because L5 and CRP are both ligands for the lectin-like oxidized LDL receptor-1 (LOX-1), we also examined the role of LOX-1.…”

Supplementary Material for: Bubble CPAP Support after Discontinuation of Mechanical Ventilation Protects Rat Lungs with Ventilator-Induced Lung Injury by Wu C.S. (3351785)

“…<b><i>Results:</i></b> The bubble technique (2.5 and 5.5 mm diameter combined) resulted in a significantly higher PaO₂, decreased alveolar protein levels (1.01 vs. 1.43 mg/kg, p < 0.05), a lower lung injury score (3.87 vs. 4.86, p < 0.05), and decreased NOS3 expression (1.99 vs. 3.32, p < 0.05) compared to spontaneous breathing in the control group. …”

The impact on the Living Planet Index (LPI) of halving or halting bottom trawling in six ocean systems, based on biomass trends in modelled vertebrate groups represented in the LPI... by Emily Nicholson (150790)

“…<p>Columns show the % change in the LPI 30 years after implementation of the policies, and the % change in total vertebrate biomass; and for each taxonomic group, the general biomass trends for different species groups from the Ecopath models from halting bottom trawling (the general biomass trends per group were typically stronger under a halt in bottom trawling than under a halving of effort); symbols: – <5% change, >5% increase, >20% increase, >5% decrease, >20% decrease, ∼ mixed: different responses were seen across models, species and/or functional groups, blank denotes that the group was not modelled.…”

The ladder-climbing test. by Caroline Pin-Barre (529432)

“…For the MCAO-D7 group: δ indicates a significant difference between D7 and D1 to D5; <b>§</b> indicates a significant difference between D6 and D1 to D5; ψ indicates a significant difference between D5 and D1 to D4 (p<0.001).…”

Steel slag-based silicate fertilizer suppresses grain cracking in brewer’s rice cultivar “Yamada-Nishiki” by Youshi Tazoe (20410017)

DataSheet_1_Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.docx by Hengrui Liu (2059750)

“…On the contrary, KIRC might have a lower cuproptosis activity because of the decrease in copper cell death gene expression. …”

Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? by Sabrina Jegerlehner (4110049)

“…Since 1998, the annual age-standardised mortality rate of prostate cancer slightly declined in men aged 50–69 years (absolute mean annual change -0.1/100,000, 95% CI: -0.2 to -0.1) and ≥ 70 years (absolute mean annual change -0.5/100,000, 95% CI: -0.7 to -0.3).…”